Literature DB >> 28397611

Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.

X-M Wang1, S-H Yin1, J Du2, M-L Du1, P-Y Wang3, J Wu4, C M Horbinski5, M-J Wu5, H-Q Zheng1, X-Q Xu1, W Shu2, Y-J Zhang6.   

Abstract

Retreatment of tuberculosis (TB) often fails in China, yet the risk factors associated with the failure remain unclear. To identify risk factors for the treatment failure of retreated pulmonary tuberculosis (PTB) patients, we analyzed the data of 395 retreated PTB patients who received retreatment between July 2009 and July 2011 in China. PTB patients were categorized into 'success' and 'failure' groups by their treatment outcome. Univariable and multivariable logistic regression were used to evaluate the association between treatment outcome and socio-demographic as well as clinical factors. We also created an optimized risk score model to evaluate the predictive values of these risk factors on treatment failure. Of 395 patients, 99 (25·1%) were diagnosed as retreatment failure. Our results showed that risk factors associated with treatment failure included drug resistance, low education level, low body mass index (6 months), standard treatment regimen, retreatment type, positive culture result after 2 months of treatment, and the place where the first medicine was taken. An Optimized Framingham risk model was then used to calculate the risk scores of these factors. Place where first medicine was taken (temporary living places) received a score of 6, which was highest among all the factors. The predicted probability of treatment failure increases as risk score increases. Ten out of 359 patients had a risk score >9, which corresponded to an estimated probability of treatment failure >70%. In conclusion, we have identified multiple clinical and socio-demographic factors that are associated with treatment failure of retreated PTB patients. We also created an optimized risk score model that was effective in predicting the retreatment failure. These results provide novel insights for the prognosis and improvement of treatment for retreated PTB patients.

Entities:  

Keywords:  Pulmonary tuberculosis; retreatment; risk factors; risk score

Mesh:

Substances:

Year:  2017        PMID: 28397611      PMCID: PMC9203337          DOI: 10.1017/S0950268817000656

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  22 in total

1.  Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.

Authors:  Songhua Chen; Pengcheng Huai; Xiaomeng Wang; Jieming Zhong; Xinting Wang; Kai Wang; Lixia Wang; Shiwen Jiang; Jun Li; Ying Peng; Wei Ma
Journal:  Int J Infect Dis       Date:  2013-08-02       Impact factor: 3.623

2.  Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.

Authors:  Anton Mak; Adam Thomas; Mirtha Del Granado; Richard Zaleskis; Nigor Mouzafarova; Dick Menzies
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

Review 3.  Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

Authors:  A Faustini; A J Hall; C A Perucci
Journal:  Thorax       Date:  2005-10-27       Impact factor: 9.139

4.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

5.  Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.

Authors:  A L Kritski; L S Rodrigues de Jesus; M K Andrade; E Werneck-Barroso; M A Vieira; A Haffner; L W Riley
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

6.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Authors:  M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

7.  Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.

Authors:  Edward C Jones-López; Irene Ayakaka; Jonathan Levin; Nancy Reilly; Francis Mumbowa; Scott Dryden-Peterson; Grace Nyakoojo; Kevin Fennelly; Beth Temple; Susan Nakubulwa; Moses L Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Jerrold J Ellner; Peter G Smith; Roy D Mugerwa
Journal:  PLoS Med       Date:  2011-03-15       Impact factor: 11.069

8.  Applying the Framingham risk score for prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran.

Authors:  Gholamreza Yousefzadeh; Mostafa Shokoohi; Hamid Najafipour; Mitra Shadkamfarokhi
Journal:  ARYA Atheroscler       Date:  2015-05

9.  Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score.

Authors:  Shevin T Jacob; Patricia B Pavlinac; Lydia Nakiyingi; Patrick Banura; Jared M Baeten; Karen Morgan; Amalia Magaret; Yuka Manabe; Steven J Reynolds; W Conrad Liles; Anna Wald; Moses L Joloba; Harriet Mayanja-Kizza; W Michael Scheld
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Arif A Khokhar; Joseph M Massaro; Seth T Lirette; Michael E Griswold; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Adolfo Correa; Ralph B D'Agostino; Steven R Jones; Peter P Toth
Journal:  J Am Heart Assoc       Date:  2016-04-29       Impact factor: 5.501

View more
  3 in total

1.  Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique.

Authors:  Damiano Pizzol; Nicola Veronese; Claudia Marotta; Francesco Di Gennaro; Jorge Moiane; Kajal Chhaganlal; Laura Monno; Giovanni Putoto; Walter Mazzucco; Annalisa Saracino
Journal:  BMC Res Notes       Date:  2018-02-05

2.  Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.

Authors:  Ninfa Marlen Chaves Torres; Jecxy Julieth Quijano Rodríguez; Pablo Sebastián Porras Andrade; María Belen Arriaga; Eduardo Martins Netto
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

3.  Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.

Authors:  Kefyalew Addis Alene; Kerri Viney; Darren J Gray; Emma S McBryde; Zuhui Xu; Archie C A Clements
Journal:  PLoS One       Date:  2020-01-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.